Embla Medical hf (OCSE:EMBLA) 3-Year EBITDA Growth Rate : 23.00% (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf 3-Year EBITDA Growth Rate?

Embla Medical hf's EBITDA per Share for the three months ended in Mar. 2024 was kr0.48.

During the past 12 months, Embla Medical hf's average EBITDA Per Share Growth Rate was 16.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 23.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 2.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Embla Medical hf was 41.80% per year. The lowest was -5.60% per year. And the median was 14.70% per year.

Competitive Comparison of Embla Medical hf's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Embla Medical hf's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Embla Medical hf's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's 3-Year EBITDA Growth Rate falls into.

Embla Medical hf 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Embla Medical hf (OCSE:EMBLA) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Embla Medical hf 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Embla Medical hf (OCSE:EMBLA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

OSSFF:USA OSSUY:USA

Address

Grjothals 5, Reykjavik, ISL

Website

https://www.ossur.com

Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines